Resonance Health Ltd has released a press release.
HepaFat-Scan International Scientific Journal
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from Resonance Health
- Operational Update
- New UK Standards recommend FerriScan
- Appendix 4C Quarterly Cashflow Report
- Placement and entitlements offer to raise $5.1million
- Half Year Accounts
Later from Resonance Health
- Expansion of Involvement in Pharmaceutical Clinical Trial
- Bone Marrow Iron - Regulatory Submission
- Resonance Health commences involvement in diabetes study
- Results Recommending Use of FerriScan in Sickle Cell Disease
- Maylasian NAFLD - Diabetes Study
Follow Resonance Health into a list and get an email when it puts out news.
Follow Resonance Health